Lenus Health
Lenus Health is a UK-based digital health company that develops predictive AI software for chronic disease management, primarily COPD and Heart Failure, sold as enterprise SaaS to NHS trusts and integrated care boards across Scotland and England.
- Company typePrivate
- Founded2017
- HeadquartersEdinburgh, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Lenus Health does
Lenus Health Ltd is a UK-based digital health company founded in 2017 (spun out as a separate entity from Storm ID in 2020) that develops a predictive AI platform for chronic disease management, primarily targeting NHS trusts, integrated care boards (ICBs), and primary care networks in Scotland and England. Its core platform is built on Microsoft Azure cloud infrastructure using HL7 FHIRv4 data APIs, with a modular product suite comprising Lenus Stratify (predictive AI risk stratification models for COPD and Heart Failure), Lenus Diagnose (digital diagnostic workflow automation), and Lenus Treat (virtual ward and remote patient monitoring). Notable clinical evidence includes a 49% reduction in respiratory hospital admissions demonstrated in the RECEIVER trial, and the platform is registered as UKCA Class I and CE Class I medical device software.
The company generates revenue through multi-year software licensing (minimum 12-month contracts) and per-patient pricing for virtual wards, with solutions procured through UK public sector frameworks including G-Cloud 14, Spark DPS, and AI DPS. Its go-to-market is enterprise sales-led, targeting NHS procurement decision-makers with clinical evidence and regulatory certifications as primary selling points. Customer concentration is heavily skewed toward the NHS, with flagship deployments at NHS Greater Glasgow & Clyde, NHS Lothian, NHS Forth Valley, NHS Highland, and several English ICBs, alongside strategic commercial partnerships with AstraZeneca UK and ResMed.
Lenus Health has accumulated approximately £2.4m in disclosed grant and strategic investment funding (Innovate UK £750k in 2018, NHS AI Award £1.2m in 2021, SBRI Healthcare ~£462k in 2022, plus ResMed strategic investment in 2021) and operates with 11-50 employees from its Edinburgh headquarters and London office. The company is pursuing higher regulatory classifications (UKCA Class IIb) and was selected for the MHRA AI Airlock pilot in December 2024 alongside NICE Medtech Innovation Briefing and IDAP Pilot Programme recognition.
Lenus Health firmographics
Firmographics- Name
- Lenus Health
- Legal name
- Lenus Health Ltd
- Website
- https://lenushealth.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Lenus Health is a UK-based digital health company that develops predictive AI software for chronic disease management, primarily COPD and Heart Failure, sold as enterprise SaaS to NHS trusts and integrated care boards across Scotland and England.
- Ownership category
- akta.pro rank
Lenus Health industry classification
Industry- Product category
- Healthcare AI Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE)
- akta.pro secondary industries
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)
Keywords
Where Lenus Health is headquartered
LocationHeadquarters
- HQ city
- Edinburgh
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Lenus Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Licensing: Lenus Health solutions are available on a license basis, typically with minimum 12-month contract terms. The Digital Appointments Service is available on a license basis for a minimum period of 12 months.
- Per-Patient Pricing: Virtual wards service is available on a cost-per-patient basis for a minimum period of 12 months. Costs depend on number of patients and integrations with existing systems including patient management systems and electronic health records.
- NHS Framework Procurement: Solutions available through UK government procurement frameworks including G-Cloud 14, Spark DPS, and AI DPS, allowing public sector organizations to procure services under pre-approved terms.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Multi-year contract | Virtual wards with per-patient pricing |
| Subscription | Multi-year contract | Digital Appointments Service license |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
Lenus Health product offering
Product offeringCore offering
Lenus Health deploys clinically proven Predictive AI software for chronic disease management, primarily COPD and Heart Failure, via three core product suites: Lenus Diagnose (digital diagnostic workflow automation), Lenus Stratify (AI risk stratification), and Lenus Treat (virtual management and remote patient monitoring). The solutions are licensed on subscription and per-patient pricing to NHS trusts, integrated care boards, and primary care providers, with regulatory-cleared medical device software running on Microsoft Azure.
Product overview
Lenus Health offers a platform-plus-modules architecture built around the Lenus Health Platform, a clinically proven Predictive AI healthcare platform. Three core product suites — Lenus Diagnose (digital diagnostics automation), Lenus Stratify (Predictive AI risk stratification), and Lenus Treat (virtual management and remote monitoring) — are underpinned by the platform and interoperate with EHR systems. Additional modules include Virtual Wards, Digital Appointments (asynchronous outpatient consultations), Community Diagnostics pathways, and COPD Digital Home Care services. The portfolio addresses chronic conditions including COPD and Heart Failure, supporting diagnosis, risk stratification, treatment, and remote care across hospital and community settings.
Differentiator
Problem solved
Functional benefit
Brands
- Lenus Diagnose: Digital tools to automate diagnostic workflows for conditions including heart failure, enabling earlier diagnosis and treatment.
- Lenus Stratify®
- Lenus Treat
- Lenus Platform
Products and services
- Lenus Health Platform Integration-ready, interoperable platform built on Microsoft Azure that structures health data, generates predictive AI, and delivers actionable clinical insights at point of care. Supports multiple chronic condition pathways across any population size using HL7 FHIRv4 Data APIs, two-way data exchange, and User-Managed Access (UMA) consent protocols. Targeted at NHS trusts, ICBs, and primary care providers.
- Lenus Stratify Award-winning suite of Predictive AI models that deliver risk scores for hospital admission/readmission, mortality, and near-term emergency admission risk for chronic conditions including COPD and Heart Failure. Models are locally explainable, calibrated, and externally validated. Used by NHS clinicians for proactive intervention and population health management.
- Lenus Diagnose Digital diagnostics solution that automates clinical diagnostic workflows, accelerates time between diagnostic steps, resolves bottlenecks, and reduces face-to-face appointments. Enables hub-and-spoke community diagnostic care models for conditions including Heart Failure and COPD, evidenced to reduce waiting times from 12 months to 6 weeks in the OPERA pathway.
- Lenus Treat Award-winning virtual management solution for remote patient monitoring, virtual wards, and outpatient virtualization. Features patient app, clinician dashboard, two-way messaging, PROMS collection, and connected device data aggregation. Demonstrated to reduce hospital re-admissions and occupied bed days for chronic disease patients.
- Virtual Wards Digital service supporting earlier discharge for patients requiring specialist care and providing at-home alternatives for elective care. Available on a cost-per-patient basis for a minimum period of 12 months. Includes continuous patient support, secure health data sharing, virtual clinical team interaction, and data-powered triage.
- Digital Appointments Service Asynchronous virtual consultation service enabling patients to submit images and answers to questions over an extended window with clinicians accessing a full clinical dashboard. Covers specialties including dermatology, rheumatology, orthopaedics, and gastroenterology. Available on a license basis for a minimum period of 12 months.
- Community Diagnostics Community-based diagnostic care model including the OPERA pathway for Heart Failure, evidenced to reduce waiting times from 12 months to 6 weeks and deliver a 78% reduction in time to treatment for a population of 1.2 million.
- COPD Support Service (Digital Home Care) Remote monitoring and self-management support service for COPD patients, leveraging patient and clinical system data to support virtual wards, optimise care, and reduce hospitalisations. Evidence shows 49% reduction in admissions and 4.74 bed days saved per patient annually in the RECEIVER cohort.
Quantifiable outcome
- 49% reduction in COPD hospital admissions (RECEIVER trial)
- +9 more outcomes
Companies that use Lenus Health
Customer profileNamed customers12 records
Segments4 records
Ideal customer profiles2 records
Lenus Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability5 records
Feature5 records
Lenus Health partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered core, flagship and minor.
- NHS South East London ICBcoreAI-driven winter approach for COPD care selected for NHS England targeted funding. Partnership with Guy's & St Thomas' and Kings College Hospital NHS Trusts for COPD Winter Approach initiative.
- NHS Humber and North Yorkshire ICBcoreAI-driven winter approach for COPD care selected for NHS England targeted funding. Partnership with Humber Health Partnership for predictive AI deployment.
- NHS LothiancoreWinter pressures initiative using Lenus Stratify AI to risk stratify 25,000 COPD patients across 100+ GP practices. Partnership leverages DataLoch collaboration with University of Edinburgh for secure data processing.
- NHS Greater Glasgow and ClydeflagshipLong-standing clinical partnership hosting RECEIVER trial for COPD digital service with approximately 2,000 patients using the Lenus COPD service. NHS GG&C provides clinical leadership, patient population, SafeHaven data repository, and ongoing service delivery. Partnership includes West of Scotland Innovation Hub collaboration for AI development.
- West of Scotland Innovation HubflagshipMulti-disciplinary innovation hub providing test bed infrastructure, leadership, and support for AI projects. Key partner in Dynamic Scot COPD initiative alongside NHS GG&C.
- Digital Health & Care Innovation Centre (DHI)coreScottish Government-commissioned innovation center that signed 2-year deal for Lenus Health Platform. DHI provides developer portal, platform access for health and care developers, and co-design collaboration for digital services.
- Public Health ScotlandcoreCollaborated on COVID-19 National Notification & Digital Tracing Service. Partnership included NHS National Services Scotland Integration Hub and National Contact Tracing Management System.
- NHS National Services ScotlandcorePartner in COVID-19 National Notification & Digital Tracing Service providing Integration Hub for secure data exchange with 2M+ test results processed.
- AstraZeneca UKcoreStrategic partnership supporting respiratory care pathway optimization. AstraZeneca supports NHS Lothian deployment of Lenus Stratify and provides medical and scientific affairs collaboration. Partnership aims to improve equitable access to high-quality care.
- Microsoft AzurecoreIndustry-leading Microsoft Azure cloud supports all Lenus Health solutions. Being cloud native and Azure optimised allows scaling to meet current and future demands. Azure PaaS enables rapid delivery and agile infrastructure deployment.
- NHS EnglandcoreNHS England provided targeted COPD Winter Approach funding to ICBs utilizing Lenus solutions. Lenus selected for AI Airlock pilot scheme with MHRA in partnership with NHS AI Lab.
- University of EdinburghcoreAcademic partnership through DataLoch collaboration enabling secure data processing for NHS Lothian AI deployment. Partnership supports population health analytics.
- University of GlasgowcoreAcademic partner in clinical research and evidence development. Co-development of predictive AI models with leading respiratory specialists.
- Guy's and St Thomas' NHS Foundation TrustcoreTeaching hospital trust leading South East London ICB COPD Winter Approach initiative using Lenus AI risk stratification and digital self-management tools.
- Kings College Hospital NHS TrustcoreTeaching hospital trust partner in South East London ICB COPD Winter Approach initiative implementing Lenus solutions.
- Humber Health PartnershipcoreNHS trust leading Humber and North Yorkshire ICB COPD Winter Approach with Lenus AI deployment. Also conducted DYNAMIC-ROSE clinical trial.
- Wellcome LeapminorHealthcare partner collaborating on digital health innovation for chronic disease management.
Scale indicators10 records
Recent moves7 records
Expansion highlights6 records
Lenus Health competitors and assessment
Company assessmentDirect peers
- Doccla: UK-based virtual ward and remote patient monitoring provider serving NHS trusts with end-to-end clinical services plus a technology platform. Directly competes with Lenus Treat and Virtual Wards offerings in the NHS chronic disease and acute care market.
- Huma (formerly Medopad): Digital health platform combining RPM, predictive analytics, and decentralized clinical trial capabilities, with significant NHS and pharma deployments. Closely comparable to Lenus on the predictive AI/RPM layer and on NHS/government customer profile.
- Current Health (Best Buy Health): Continuous remote patient monitoring platform for hospital and home care, acquired by Best Buy Health. Overlaps with Lenus Treat's RPM, virtual ward, and chronic disease management use cases across multiple health systems.
- Propeller Health (ResMed): ResMed-owned digital health platform focused on respiratory disease (asthma and COPD) self-management with connected inhalers and predictive analytics. Sister company to Lenus through ResMed's investment, and the most direct respiratory chronic disease peer.
Regional players
- Luscii: Netherlands-headquartered RPM and virtual wards platform with OMRON ownership, operating across multiple European health systems. Comparable to Lenus Treat in functionality, though primarily active in continental Europe rather than the UK.
Emerging players
- Skin Analytics: UK-based dermatology AI company with Class II SaMD for skin cancer detection, deployed in NHS pathways. Compares to Lenus Diagnose on the AI diagnostic / dermatology dimension and shares the UK regulatory SaMD pathway.
Broad incumbents
- Cera Care: UK-based technology-enabled home care provider combining AI-driven workforce matching with in-home clinical services. Larger incumbent operating across chronic disease home care that overlaps with Lenus Treat's virtual ward and home monitoring positioning.
- Ada Health: Global symptom assessment and digital health platform with regulated medical device status. Comparable to Lenus Diagnose on AI-driven clinical decision support and chronic condition pathways.
- Medtronic Care Management Services: Large medtech incumbent offering connected care, remote monitoring, and AI-supported chronic disease management. Represents the strategic incumbent threat against Lenus's AI risk stratification and integrated care positioning.
- Babylon Health (eMed): UK-headquartered AI-driven digital health and triage platform that scaled across NHS and global markets. Comparable as a UK digital health incumbent focused on chronic and acute care pathways, though broader in scope than Lenus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Lenus Health social profiles
Digital presenceLenus Health compliance and trust
Trust signalCompliance11 records
Lenus Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lenus Health leadership team
Management profileNumber of profiles
Profiles5 records
Lenus Health funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lenus Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lenus Health
What does Lenus Health do?
Lenus Health deploys clinically proven Predictive AI software for chronic disease management, primarily COPD and Heart Failure, via three core product suites: Lenus Diagnose (digital diagnostic workflow automation), Lenus Stratify (AI risk stratification), and Lenus Treat (virtual management and remote patient monitoring). The solutions are licensed on subscription and per-patient pricing to NHS trusts, integrated care boards, and primary care providers, with regulatory-cleared medical device software running on Microsoft Azure.
Is Lenus Health a public or private company?
Lenus Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Lenus Health founded?
Lenus Health was founded in 2017. It employs 11 to 50 people.
Where is Lenus Health based?
Lenus Health is headquartered in Edinburgh, United Kingdom, in the Europe region.
How does Lenus Health make money?
Three revenue lines are on record. Software Licensing is the primary driver. The others are per-Patient Pricing and NHS Framework Procurement.
Who are Lenus Health's main competitors?
Direct peers on record are Doccla, Huma (formerly Medopad), Current Health (Best Buy Health) and Propeller Health (ResMed). Luscii is listed as a regional player. Skin Analytics is listed as an emerging player. Broad incumbents are Cera Care, Ada Health, Medtronic Care Management Services and Babylon Health (eMed).
Does Lenus Health have an API?
No public API is recorded for Lenus Health.
What industry is Lenus Health in?
Lenus Health's product category is Healthcare AI Software. Its primary akta.pro industry code is HLACANAE, SaMD – Monitoring, Triage & Risk Stratification Software, with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 54151 and its SIC code is 7372.